Megan Blewett
Co-founder and President
Berkeley, California
Invests in
Locations:
Min Investment:
$10,000.00Max Investment:
$100,000.00Target Investment:
$50,000.00
Skills
Education
- HU
- SR
Lists including Megan
Work Experience
2021
Co-Founder and President
2024
Co-Founder and VP Corporate Development
2021 - 2024
2022
Board Member
2022
2019 - 2021
Co-Founder and Director of Business Development
2019 - 2021
Together with Venrock partner Bryan Roberts and scientific founders Michael Birnbaum and Michael Fischbach, I helped launch lentiviral gene therapy company Kelonia Therapeutics. The Birnbaum Lab had developed a highly elegant way to target lentiviruses to specific cell types, and it was our job to build a company leveraging this technology to treat serious diseases. Most of my time was focused on indication selection strategy and business development, but what I'm most proud of is helping to recruit the founding team.
2017 - 2020
Life sciences investor
2017 - 2020
- Board observer at Federation Bio, worked on company incubation and launch - Board observer at Prothelia - Co-founder at Iris Medicine - Co-founder at Kelonia Therapeutics